StockNews.com Initiates Coverage on Aspira Women’s Health (NASDAQ:AWH)

Equities researchers at StockNews.com initiated coverage on shares of Aspira Women’s Health (NASDAQ:AWH) in a report issued on Thursday. The firm set a “hold” rating on the stock.

Separately, Cantor Fitzgerald reiterated a “neutral” rating and set a $3.30 price objective on shares of Aspira Women’s Health in a report on Wednesday, April 10th.

Aspira Women’s Health Stock Performance

NASDAQ AWH opened at $2.98 on Thursday. The stock has a market capitalization of $36.77 million, a P/E ratio of -0.25 and a beta of 1.57. Aspira Women’s Health has a 52 week low of $2.31 and a 52 week high of $6.75. The stock has a fifty day moving average of $3.38 and a 200-day moving average of $3.87.

Aspira Women’s Health (NASDAQ:AWH) last posted its quarterly earnings results on Thursday, March 28th. The company reported ($0.30) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.39) by $0.09. Aspira Women’s Health had a negative return on equity of 1,099.32% and a negative net margin of 176.74%. The company had revenue of $2.13 million for the quarter, compared to the consensus estimate of $2.70 million. Equities research analysts forecast that Aspira Women’s Health will post -1.24 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Aspira Women’s Health

Several hedge funds have recently bought and sold shares of the stock. Northeast Financial Consultants Inc acquired a new stake in Aspira Women’s Health during the third quarter worth about $126,000. Quantum Private Wealth LLC raised its position in shares of Aspira Women’s Health by 76.8% in the 4th quarter. Quantum Private Wealth LLC now owns 50,156 shares of the company’s stock valued at $205,000 after buying an additional 21,788 shares in the last quarter. B. Riley Wealth Advisors Inc. lifted its holdings in shares of Aspira Women’s Health by 39.0% during the 3rd quarter. B. Riley Wealth Advisors Inc. now owns 125,374 shares of the company’s stock worth $672,000 after acquiring an additional 35,177 shares during the period. Finally, Perkins Capital Management Inc. acquired a new stake in shares of Aspira Women’s Health during the 3rd quarter worth approximately $268,000. 12.19% of the stock is currently owned by institutional investors and hedge funds.

About Aspira Women’s Health

Aspira Women's Health Inc, together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company's products include Ova1, a blood test intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker reflex test; and Ova1Plus, a reflex offering.